HER2 positivity was less common among participants living with HIV, although this difference did not reach statistical significance (18% vs 35%; P = 0.067).
← all excerpts
Baseline clinical and laboratory profiles at breast cancer diagnosis in Tanzania: differences by HIV status.
1
0.0670
0.0670